Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Envelope-type nano device for gene delivery].

Kentaro Kogure1, Hidetaka Akita, Hideyoshi Harashima

  • 1Graduate School of Pharmaceutical Sciences, Hokkaido University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combining Anti-Inflammatory Drugs and Cell-Specific Expression-Suppression Reduces the Adjuvant Activity of mRNA-LNPs.

Molecular pharmaceutics·2026
Same author

Lipid nanoparticle-encapsulated microRNA-192: An anti-inflammatory adjuvant that enhances vaccine efficacy in aged mice.

Molecular therapy. Nucleic acids·2025
Same author

Lipid nanoparticle-mediated mRNA delivery system into preimplantation embryos†.

Biology of reproduction·2025
Same author

Combination of ionizable lipids with oleic acid and vitamin E scaffolds for RNA cancer vaccine delivery.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

Neoantigen mRNA vaccines induce progenitor-exhausted T cells that support anti-PD-1 therapy in gastric cancer with peritoneal metastasis.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2025
Same author

Modulating Immunogenicity and Reactogenicity in mRNA-Lipid Nanoparticle Vaccines through Lipid Component Optimization.

ACS nano·2025

We developed "Programmed Packaging," a new strategy for creating effective non-viral gene delivery systems by overcoming nanoparticle packaging challenges for in vitro applications.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Nanomedicine

Context:

  • Non-viral gene delivery systems are crucial for in vitro research but face limitations.
  • Difficulty in packaging multiple functional components into nanoparticles hinders their utility.
  • Existing systems often struggle with efficient in vitro gene transfer.

Purpose:

  • To introduce a novel concept, Programmed Packaging, for rational non-viral gene delivery system development.
  • To address the challenge of incorporating diverse functional elements into nanoparticles.
  • To enhance the efficacy of gene delivery systems for in vitro applications.

Summary:

  • Programmed Packaging integrates targeting strategies, molecular design for barrier penetration, and assembly techniques.

Related Experiment Videos

  • This approach facilitates the efficient packaging of multiple functional devices within a single nanoparticle.
  • The article details the Programmed Packaging concept and presents newly developed gene delivery systems based on it.

    • Impact:

    • Enables the rational design of advanced non-viral gene delivery vectors.
    • Overcomes key limitations in current in vitro gene delivery technologies.
    • Paves the way for more effective and versatile gene therapy research tools.